SCIENTIFIC AGENDA

Submit your

ABSTRACT

Last Date for

SUBMISSION

September 05, 2025

Submission Closed

CONTENT SPECIFICATIONS

  • Structure
    ABSTRACTS should be structured under the given headings
    • Title

      (should be concise and to the point, clearly conveying the subject of the abstract)

    • Introduction

      (briefly and clearly describe the objectives and the hypothesis of the study)

    • Aims & Objectives
    • Methods & Materials

      (should describe the study material or study subjects including details of the experimental material and methods employed in the study)

    • Results

      (should describe the results of your study in a logical sequence)

    • Conclusion

      (should emphasise new and important aspects of the study and conclusions that are drawn from them)

  • CASE STUDY
    Case Study should be structured under the given headings
    • Title

      (should be concise and to the point, clearly conveying the subject of the abstract)

    • Introduction
    • Case Description
    • Conclusion

      (mention why the case is unique and worth presenting)

  • 350

    Word Count

    limited to 350 words, excluding the title
  • 40 words

    Title

    limited to 40 words, don't put full stop (.) at the end of the title
  • English

    Language

    English, clear and concise

Please proofread the abstract for spelling and grammar before submitting it.


No images, graphs, tables, references or illustrations are allowed.


The brand names or name of the manufacturers for any drug or equipment is strictly prohibited. Use generic name(s).


Use numerals to indicate numbers, except to begin sentences.


Standard abbreviations are acceptable. Uncommon abbreviations must be put in parentheses and preceded by the full word the first time it appears in the text.

RESPONSIBILITIES OF THE AUTHORS INCLUDE

  • The data presented should be the original work of the author and have not been plagiarized from any other source.
  • We do not accept work that has been previously published or presented, or that is scheduled to be published or presented prior to the conference.
  • Avoid personal criticisms of individuals in the abstract. Criticism should be restricted to scientific contents, based on evidence.

SUBMISSION SPECIFICATIONS

Topics
Abstracts can be submitted under the following topics
  • Basic Sciences
  • Clinical Nephrology
  • Dialysis
  • Transplant
  • Each topic category will accept submissions for Oral and Poster, both. DO NOT SUBMIT THE SAME PAPER FOR MORE THAN ONE CATEGORY.
  • One can submit in ORAL and POSTER categories, both. One can submit only THREE abstracts in the ORAL category. No limit for POSTER category submission.
  • Abstracts, SUBMITTED ONLINE ONLY, will be accepted. Abstracts sent via mail will not be accepted for review. Late submission will not be accepted.
  • PRESENTING AUTHOR

  • The Presenting author MUST BE a registered delegate. Submitting an abstract DOES NOT REGISTER you for ISN EZCON 2025 unless the payment formalities are completed.
  • In case of an exception, the scientific committee will make the decision. All correspondence (regarding review, selection and presentation details) will be mailed to the PRESENTING AUTHOR ONLY
  • ALL ABSTRACT SUBMITTERS ARE HEREBY REQUESTED TO GO THROUGH THE FOLLOWING CAREFULLY

  • Author and co-author details - Full name, affiliation details such as department, institution/hospital, city, state, country should be mentioned properly.
  • Contact details (e-mail, ph no) of the presenting author should be mentioned properly. Please do not mention any other contact.
  • COPYRIGHT

  • Submission of the abstract signifies the author’s consent to publish (in case) the same as a part of ISN EZCON 2025 proceedings.
  • The scientific committee also reserves the right to reproduce the abstracts/presentations made in the conference in print or electronic media.
  • ABSTRACT REVISION

  • Submitted abstracts could be EDITED or REVISED ONLINE ONLY
  • Please log in to your ISN EZCON 2025 profile for the same
  • Abstracts can be revised till the submission is open
  • PLEASE AVOID THE RESUBMISSION OF THE SAME ABSTRACT

REVIEW SPECIFICATIONS

  • All abstracts will be reviewed online by an experts' panel through an unbiased, blinded selection process. Abstracts will be selected on the basis of their medical and scientific content, quality of data and methodology and adherence to specific format requirements.
  • Once selected, the Presenting Author of the selected abstract will be informed accordingly via email.
  • The scientific committee holds the sole right to accept or reject papers, to assign those for an oral or e-poster presentation and to decide on the final slot allocation.

A paper can be rejected

  • If the presentation has been delivered earlier in any format in any previous ISNEZCON conference
  • If the paper remains incomplete
  • If it does not comply with all the guidelines
  • If it is not having expected scientific merit

TIMELINES

  • Last Date for Submission: October 15, 2025
  • Abstracts Disposition Notification: November 15, 2025